These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30510202)

  • 1. Engineered K1F bacteriophages kill intracellular Escherichia coli K1 in human epithelial cells.
    Møller-Olsen C; Ho SFS; Shukla RD; Feher T; Sagona AP
    Sci Rep; 2018 Dec; 8(1):17559. PubMed ID: 30510202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage K1F targets Escherichia coli K1 in cerebral endothelial cells and influences the barrier function.
    Møller-Olsen C; Ross T; Leppard KN; Foisor V; Smith C; Grammatopoulos DK; Sagona AP
    Sci Rep; 2020 Jun; 10(1):8903. PubMed ID: 32483257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a broad host range lytic bacteriophage against E. coli adhered to urothelium.
    Sillankorva S; Oliveira D; Moura A; Henriques M; Faustino A; Nicolau A; Azeredo J
    Curr Microbiol; 2011 Apr; 62(4):1128-32. PubMed ID: 21140149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Engineering of Bacteriophage K1F with Human Epidermal Growth Factor to Enhance Killing of Intracellular
    Williams J; Kerven J; Chen Y; Sagona AP
    ACS Synth Biol; 2023 Jul; 12(7):2094-2106. PubMed ID: 37318278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genome of bacteriophage K1F, a T7-like phage that has acquired the ability to replicate on K1 strains of Escherichia coli.
    Scholl D; Merril C
    J Bacteriol; 2005 Dec; 187(24):8499-503. PubMed ID: 16321955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Characterization and In Vivo Efficacy Assessment in
    Antoine C; Laforêt F; Blasdel B; Fall A; Duprez JN; Mainil J; Delcenserie V; Thiry D
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transposable Element Insertions into the Escherichia coli Polysialic Acid Gene Cluster Result in Resistance to the K1F Bacteriophage.
    Styles KM; Locke RK; Cowley LA; Brown AT; Sagona AP
    Microbiol Spectr; 2022 Jun; 10(3):e0211221. PubMed ID: 35467398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic
    Slobodníková L; Markusková B; Kajsík M; Andrezál M; Straka M; Liptáková A; Drahovská H
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage Targeting Neonatal Meningitis
    Antoine C; Laforêt F; Goya-Jorge E; Gonza I; Lebrun S; Douny C; Duprez JN; Fall A; Taminiau B; Scippo ML; Daube G; Thiry D; Delcenserie V
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445758
    [No Abstract]   [Full Text] [Related]  

  • 11. Phage therapy targeting Escherichia coli-a story with no end?
    Bolocan AS; Callanan J; Forde A; Ross P; Hill C
    FEMS Microbiol Lett; 2016 Nov; 363(22):. PubMed ID: 27974392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections.
    Barros J; Melo LDR; Poeta P; Igrejas G; Ferraz MP; Azeredo J; Monteiro FJ
    Int J Antimicrob Agents; 2019 Sep; 54(3):329-337. PubMed ID: 31229670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection.
    Terwilliger A; Clark J; Karris M; Hernandez-Santos H; Green S; Aslam S; Maresso A
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli.
    Yu L; Wang S; Guo Z; Liu H; Sun D; Yan G; Hu D; Du C; Feng X; Han W; Gu J; Sun C; Lei L
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):971-983. PubMed ID: 29150707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Morphological Fates of Uropathogenic
    Iosifidis G; Duggin IG
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32540870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing urinary tract infections through phage therapy: a novel approach.
    Malik S; Sidhu PK; Rana JS; Nehra K
    Folia Microbiol (Praha); 2020 Apr; 65(2):217-231. PubMed ID: 31494814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
    Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a Chicken Embryo Lethality Assay to Assess the Efficacy of Phage Therapy.
    Trotereau A; Schouler C
    Methods Mol Biol; 2019; 1898():199-205. PubMed ID: 30570735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model.
    Mijbel Ali B; Gatea Kaabi SA; Al-Bayati MA; Musafer HK
    Arch Razi Inst; 2021 Nov; 76(5):1229-1236. PubMed ID: 35355758
    [No Abstract]   [Full Text] [Related]  

  • 20. A non-canonical autophagy-dependent role of the ATG16L1
    Wang C; Bauckman KA; Ross ASB; Symington JW; Ligon MM; Scholtes G; Kumar A; Chang HW; Twentyman J; Fashemi BE; Xavier RJ; Mysorekar IU
    Autophagy; 2019 Mar; 15(3):527-542. PubMed ID: 30335568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.